Home/Filings/4/0001214659-18-003952
4//SEC Filing

Goldfarb Robert I 4

Accession 0001214659-18-003952

CIK 0001625288other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:30 PM ET

Size

8.1 KB

Accession

0001214659-18-003952

Insider Transaction Report

Form 4
Period: 2018-05-05
Goldfarb Robert I
Chief Operating Officer
Transactions
  • Exercise of In-Money

    Common Stock

    2018-05-05$0.38/sh+2,400$9121,028,800 total
  • Exercise of In-Money

    Class B Warrants (right to buy)

    2018-05-052,4000 total
    Exercise: $0.38From: 2017-11-29Exp: 2018-06-07Common Stock (2,400 underlying)
Holdings
  • Class C Warrants (right to buy)

    Exercise: $0.50From: 2017-11-29Exp: 2018-07-14Common Stock (2,400 underlying)
    2,400
Footnotes (1)
  • [F1]Acquired in exchange for all of Robert Goldfarb's Class B warrants of Intiva BioPharma Inc.

Issuer

Intiva BioPharma Inc.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001337910

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:30 PM ET
Size
8.1 KB